07 January 2015 | News | By BioSpectrum Bureau
Canada quarantines APIs by India firm
Canadian importers have stopped distributing APIs from Sri Krishna Pharmaceuticals
Singapore: Canada has quarantined the health products made with active pharmaceutical ingredients (APIs) from India's Sri Krishna Pharmaceuticals due to data integrity concerns.
Health Canada is taking the action as an interim precautionary measure to help mitigate any potential risk.
Under the quarantine measures, Canadian importers and distributors have stopped distributing APIs or finished dosage form products containing active ingredients from this site. At this time there is no identified risk to health, and Health Canada is not requesting a recall of any of the products.
Health Canada has stated that the action applies to APIs from Sri Krishna Pharmaceuticals, which are used to make finished drug products that are sold to consumers. Health Canada has compiled an initial list of products affected by the quarantine. The list will be updated as new information becomes available.